Eric Karas is Chief Commercial Officer of ARS Pharmaceuticals Inc.
Person profile
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Jan 24 | SPRY ARS Pharmaceuticals | Stock option Common Stock | Grant | Acquire A | No | No | 5.58 | 200,000 | 1.12 mm | 200,000 |
3 Jan 23 | SPRY ARS Pharmaceuticals | Stock option Common Stock | Grant | Acquire A | No | No | 8.42 | 50,000 | 421.00 k | 50,000 |